Suppression of mobile elements by p53 genes
p53 基因对移动元件的抑制
基本信息
- 批准号:10308726
- 负责人:
- 金额:$ 34.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAllelesAnimalsApoptosisBindingBiologyBiology of AgingBiosensorCancer PatientCellsChimera organismChromatinClinicCodeComplementDNA RepairDefectDeltastabDepositionDiagnosisDisabled PersonsDiseaseDrosophila genusElementsEpigenetic ProcessFishesGene FamilyGenesGeneticGenetic ModelsGenetic TranscriptionGenomeGoalsHealthHeritabilityHumanHuman PathologyHyperactivityIndividualInstructionLinkMalignant NeoplasmsMediatingModalityModelingMolecularMusMutant Strains MiceMutateOncogenicPathologyPhenotypePositioning AttributeProcessPropertyProtein IsoformsProteinsRegulationReportingRepressionResourcesRetroelementsRetrotransposonRouteSpecific qualifier valueStressSystemTP53 geneTimeTrans-ActivatorsTranscriptional ActivationTumor Suppressionage relatedbiological adaptation to stresscancer preventioncell growthcell injuryflygenome-widehuman diseaseimprovedin vivoinnovationinsightloss of functionmutantpreventreconstitutionresponsesenescencetooltranscription factortumorvirtual
项目摘要
Summary
The p53 gene family occupies central positions in stress response networks throughout the animal
kingdom and, as transcription factors, these proteins specify robust adaptive responses. Furthermore,
the human counterpart is broadly implicated in age-related diseases including most cancers. Yet despite
extensive characterization, disease deterrence by p53 is not well understood and conventional
explanations for how p53 prevents oncogenic transformation have been fundamentally challenged.
Since p53 genes are broadly conserved, ancestral properties of these genes offer promising routes
towards understanding functions that become deranged in human diseases. Toward this goal, we built
tools to explore the p53 regulatory network in genetic models, enabling unique opportunities to
interrogate conserved properties that support human pathologies. These resources include in vivo
biosensors that visualize real-time p53 action and complementation platforms that exchange human
alleles for the fly counterpart. Leveraging these tools in flies and in fish, we discovered that p53 is
acutely sensitive to - and normally restrains - retrotransposons, which are mobile elements broadly
implicated in human disease. Likewise, we further showed that human p53 genes could similarly restrain
transposons, but mutated p53 alleles from cancer patients could not. These combined discoveries
suggest that p53 acts through highly conserved mechanisms to restrict transposons. Furthermore, since
human p53 mutants are disabled for this activity, our findings raise the possibility that p53 mitigates
disease, in part, by suppressing the activity of transposons. Consistent with this, we exposed
hyperactive retrotransposons in p53-driven cancers and found co-repression activity that is obligate for
p53 suppression. Initiatives advanced in this proposal build on these discoveries to determine precisely
how p53 restrains mobile elements. Our approach integrates genetic models with molecular systems to
deconstruct this process. Within this framework, we may deliver new opportunities for improved
diagnosis and treatment of conditions fueled by dysfunctional p53.
总结
p53基因家族在整个动物的应激反应网络中占据中心位置
作为转录因子,这些蛋白质指定了强大的适应性反应。此外,委员会还认为,
人类对应物与包括大多数癌症在内的与年龄有关的疾病广泛相关。然而尽管
广泛的表征,p53的疾病威慑尚未得到很好的理解和常规
对p53如何阻止致癌转化的解释已经受到根本性的挑战。
由于p53基因是广泛保守的,这些基因的祖先特性提供了有前途的路线
对理解人类疾病中的紊乱功能有很大的帮助。为了实现这一目标,我们建立了
在遗传模型中探索p53调控网络的工具,使独特的机会,
询问支持人类病理学的保守特性。这些资源包括体内
实时可视化p53作用和互补平台的生物传感器,
果蝇的等位基因利用苍蝇和鱼类的这些工具,我们发现p53是
对反转录转座子非常敏感,通常会抑制反转录转座子,反转录转座子是广泛的移动的元件
与人类疾病有关同样,我们进一步表明,人类p53基因可以类似地抑制
转座子,但突变的p53等位基因从癌症患者不能。这些综合发现
表明p53通过高度保守的机制来限制转座子。此外,由于
人类p53突变体不能进行这种活性,我们的发现提高了p53减轻这种活性的可能性。
疾病,部分是通过抑制转座子的活性。与此相一致,我们暴露了
在p53驱动的癌症中过度活跃的反转录转座子,并发现了专性的共抑制活性,
p53抑制。该提案中提出的倡议建立在这些发现的基础上,
p53如何抑制移动的元素。我们的方法将遗传模型与分子系统相结合,
解构这个过程。在这个框架内,我们可以提供新的机会,
诊断和治疗由功能失调的p53引起的病症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John M Abrams其他文献
Caspase activation – stepping on the gas or releasing the brakes? Lessons from humans and flies
半胱天冬酶激活——踩油门还是踩刹车?来自人类和果蝇的教训
- DOI:
10.1038/sj.onc.1207522 - 发表时间:
2004-04-12 - 期刊:
- 影响因子:7.300
- 作者:
Guy S Salvesen;John M Abrams - 通讯作者:
John M Abrams
John M Abrams的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John M Abrams', 18)}}的其他基金
Tumor suppression, p53 and retrotransposons
肿瘤抑制、p53 和逆转录转座子
- 批准号:
10465065 - 财政年份:2018
- 资助金额:
$ 34.44万 - 项目类别:
Tumor suppression, p53 and retrotransposons
肿瘤抑制、p53 和逆转录转座子
- 批准号:
10215433 - 财政年份:2018
- 资助金额:
$ 34.44万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 34.44万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 34.44万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 34.44万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 34.44万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 34.44万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 34.44万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 34.44万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 34.44万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 34.44万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 34.44万 - 项目类别:
Research Grant














{{item.name}}会员




